CME Group Inc., US12572Q1058

CME Group stock reports record Q3 trading volume

Published on 10/06/2026 at 17:53 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

CME Group stock set a September volume record of 31.8 million contracts, up 22 percent year over year on October 2. TD Cowen lifted its target to USD 300 from USD 292.

Fotorealistisches Bild eines modernen Derivate-Handelsraums mit Monitoren und Händlern
CME Group Inc. Handelsparkett mit Futures-Bildschirmen, ISIN US12572Q1058 repräsentiert den globalen Derivatemarkt, Illustration mit AI erstellt.

CME Group stock (ISIN US12572Q1058) was trading at USD 270.53 on Nasdaq on October 6, 2026 at 11:52 a.m. ET, up 0.18 percent from USD 270.03. The exchange operator's latest volume report points to sustained activity across rates, equities, energy and foreign exchange markets.

Record volume sets the tone

According to CME Group on October 2, 2026, September average daily volume reached a record 31.8 million contracts, up 22 percent from the prior year. Q3 average daily volume reached 29.4 million contracts, up 16 percent year over year.

The breadth of the increase matters for CME Group's earnings profile. Q3 interest-rate volume rose 13 percent to 15.1 million contracts, while equity-index volume increased 23 percent to 7.7 million and energy volume advanced 16 percent to 2.7 million, according to the same October 2, 2026 release from CME Group.

Q2 beat met a revenue test

Second-quarter 2026 adjusted earnings per share came in at USD 2.99 against a USD 2.95 estimate, while revenue reached USD 1.71 billion versus a USD 1.72 billion forecast, as Investing.com reported on October 5, 2026. The mixed comparison puts the September and Q3 volume figures at the center of the next earnings test.

CME Group is scheduled to report third-quarter 2026 results on October 21, 2026. Zacks lists a consensus estimate of USD 2.96 earnings per share for the September quarter, a 10.45 percent increase from the comparable period, according to its earnings calendar.

Analysts lift targets ahead

TD Cowen raised its price target to USD 300 from USD 292 and kept a Buy rating on October 5, 2026, citing stronger third-quarter average daily volume and higher repurchase activity, according to Investing.com. The USD 300 target lies 10.9 percent above the October 6 price.

The broader analyst consensus was Hold among 16 analysts, with an average target of USD 283.60, according to MarketScreener. That average target lies 4.8 percent above the current price, leaving the volume trend and the October 21 earnings report as the next measurable checkpoints.

Stock stays below yearly high

CME Group stock was 17.8 percent below its USD 329.16 52-week high on October 6, 2026, while its USD 218.31 low and USD 97.3 billion market capitalization frame the current valuation picture. At 11:52 a.m. ET, the shares were trading at USD 270.53 on Nasdaq.

CME Group stock key facts

  • Company: CME Group Inc.
  • ISIN: US12572Q1058
  • Ticker: CME
  • Trading venue: Nasdaq
  • Price (as of October 6, 2026, 11:52 a.m. ET): USD 270.53
  • Market capitalization: USD 97.3 billion (as of October 6, 2026)
  • 52-week range: USD 218.31-329.16 (as of October 6, 2026)
  • Sector / Industry: Financial and Commodity Market Operators
  • Index membership: S&P 500

Upcoming dates for CME Group stock

  • October 21, 2026: Q3 2026 earnings release

More news and analyses on CME Group stock

Disclaimer...

en | US12572Q1058 | CME GROUP INC. | boerse | 70244123 | bgmi